胆道支架在恶性胆道梗阻中的研究进展

摘要/Abstract

摘要：

恶性胆道梗阻（MBO）是胆道处发生梗阻而引起胆汁排出受阻，导致皮肤黄染、瘙痒、肝功能受损表现，通常由胆管部、胰头部、壶腹部肿瘤或远处肿瘤转移侵袭压迫所致。因其症状隐匿性和恶性程度高，患者5年生存率极低，多数患者错失手术机会。逆行胰胆管造影联合胆道支架的内引流术在MBO姑息性治疗中具有重大优势。

关键词:恶性胆道梗阻,内镜下逆行性胰胆管造影,胆道支架,手术后并发症

Abstract:

Malignant biliary obstruction （MBO） refers to the obstruction of the biliary tract， which usually causes obstruction of bile discharge， leading to skin yellow staining， itching， and impaired liver function. MBO can be caused by bile duct， pancreatic head， jugular tumor or distant tumor metastasis invasion and compression. Because of its insidious symptoms and high degree of malignancy， the 5-year survival rate is extremely low， and most patients miss the opportunity of surgery. Therefore， endoscopic retrograde cholangiopancreatography combined with internal biliary stents drainage has significant advantages in the palliative treatment of MBO.

Key words:Malignant biliary obstruction,Endoscopic retrograde cholangiopancreatography,Biliary stents,Postoperative complications

廖俊, 祖洪亮. 胆道支架在恶性胆道梗阻中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(11): 728-733.

Liao Jun, Zu Hongliang. Advances in the study of biliary stents in malignant biliary obstruction[J]. Journal of International Oncology, 2024, 51(11): 728-733.

参考文献47

[1]	周蔚文, 孙晓南. 肝外胆管癌放疗的研究进展[J].国际肿瘤学杂志,2020,47(7): 431-435. DOI:10.3760/cma.j.cn371439-20200224-00051.
[2]	龙欣, 吴晗, 彭晋, 等. 晚期胆道系统恶性肿瘤的系统治疗[J].国际肿瘤学杂志,2021,48(5): 302-307. DOI:10.3760/cma.j.cn371439-20200819-00058.
[3]	He X, Zhu Y, Wang Y, et al. Advances in stent therapy for malignant biliary obstruction[J].Abdom Radiol (NY),2021,46(1): 351-361. DOI:10.1007/s00261-020-02593-5.
[4]	Vaishnavi C, Samanta J, Kochhar R. Characterization of biofilms in biliary stents and potential factors involved in occlusion[J].World J Gastroenterol,2018,24(1): 112-123. DOI:10.3748/wjg.v24.i1.112.
[5]	Lam R, Muniraj T. Fully covered metal biliary stents: a review of the literature[J].World J Gastroenterol,2021,27(38): 6357-6373. DOI:10.3748/wjg.v27.i38.6357.
[6]	Nakai Y, Isayama H, Wang HP, et al. International consensus statements for endoscopic management of distal biliary stricture[J].J Gastroenterol Hepatol,2020,35(6): 967-979. DOI:10.1111/jgh.14955.
[7]	Fugazza A, Fabbri C, Di Mitri R, et al. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction after failed ERCP: a retrospective nationwide analysis[J].Gastrointest Endosc,2022,95(5): 896-904.e1. DOI:10.1016/j.gie.2021.12.032. pmid:34995640
[8]	Song G, Zhao HQ, Liu Q, et al. A review on biodegradable biliary stents: materials and future trends[J].Bioact Mater,2022,17: 488-495. DOI:10.1016/j.bioactmat.2022.01.017. pmid:35415292
[9]	Siiki A, Rinta-Kiikka I, Sand J, et al. A pilot study of endoscopically inserted biodegradable biliary stents in the treatment of benign biliary strictures and cystic duct leaks[J].Gastrointest Endosc,2018,87(4): 1132-1137. DOI:10.1016/j.gie.2017.10.042.
[10]	Battistel M, Senzolo M, Ferrarese A, et al. Biodegradable biliary stents for percutaneous treatment of post-liver transplantation refractory benign biliary anastomotic strictures[J].Cardiovasc Intervent Radiol,2020,43(5): 749-755. DOI:10.1007/s00270-020-02442-4. pmid:32133551
[11]	Peng H, Fan K, Zan R, et al. Degradable magnesium implants inhibit gallbladder cancer[J].Acta Biomater,2021,128: 514-522. DOI:10.1016/j.actbio.2021.04.051. pmid:33964481
[12]	Yang K, Sun W, Cui L, et al. Advances in functional coatings on biliary stents[J].Regen Biomater,2024,11: rbae001. DOI:10.1093/rb/rbae001.
[13]	Kobayashi M. Development of a biliary multi-hole self-expandable metallic stent for bile tract diseases: a case report[J].World J Clin Cases,2019,7(11): 1323-1328. DOI:10.12998/wjcc.v7.i11.1323. pmid:31236396
[14]	Park JS, Jeong S, Lee DH, et al. Antitumor effect of the paclitaxel-eluting membrane in a mouse model[J].Oncol Lett,2018,16(4): 4537-4542. DOI:10.3892/ol.2018.9164.
[15]	Xiao JB, Weng JY, Hu YY, et al. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma[J].World J Gastroenterol,2020,26(31): 4589-4606. DOI:10.3748/wjg.v26.i31.4589.
[16]	Boyer CJ, Boktor M, Samant H, et al. 3D printing for bio-synthetic biliary stents[J].Bioengineering (Basel),2019,6(1): 16. DOI:10.3390/bioengineering6010016.
[17]	Kim JH, Ha DH, Han ES, et al. Feasibility and safety of a novel 3D-printed biodegradable biliary stent in an in vivo porcine model: a preliminary study[J].Sci Rep,2022,12(1): 15875. DOI:10.1038/s41598-022-19317-y. pmid:36151222
[18]	Lee H, Won DS, Park S, et al. 3D-printed versatile biliary stents with nanoengineered surface for anti-hyperplasia and antibiofilm formation[J].Bioact Mater,2024,37: 172-190. DOI:10.1016/j.bioactmat.2024.03.018. pmid:38549771
[19]	Jang S, Stevens T, Parsi MA, et al. Superiority of self-expandable metallic stents over plastic stents in treatment of malignant distal biliary strictures[J].Clin Gastroenterol Hepatol,2022,20(2): e182-e195. DOI:10.1016/j.cgh.2020.12.020.
[20]	Kumar N, Jena A, Sharma V, et al. Outcome of metal vs plastic stents for biliary obstruction in patients with pancreatic carcinoma undergoing neoadjuvant chemoradiotherapy: a systematic review and meta-analysis[J].J Hepatobiliary Pancreat Sci,2023,30(4): 419-428. DOI:10.1002/jhbp.1240.
[21]	Kuwatani M, Kawakubo K, Sugimori K, et al. Trial protocol: a randomised controlled trial to verify the non-inferiority of a partially covered self-expandable metal stent to an uncovered self-expandable metal stent for biliary drainage during neoadjuvant therapy in patients with pancreatic cancer with obstructive jaundice (PUN-NAC trial)[J].BMJ Open,2021,11(7): e045698. DOI:10.1136/bmjopen-2020-045698.
[22]	Tringali A, Hassan C, Rota M, et al. Covered vs. Uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis[J].Endoscopy,2018,50(6): 631-641. DOI:10.1055/s-0043-125062. pmid:29342491
[23]	Kulpatcharapong S, Piyachaturawat P, Mekaroonkamol P, et al. Efficacy of multi-hole self-expandable metal stent compared to fully covered and uncovered self-expandable metal stents in patients with unresectable malignant distal biliary obstruction: a propensity analysis[J].Surg Endosc,2024,38(1): 212-221. DOI:10.1007/s00464-023-10541-9.
[24]	Watanabe M, Okuwaki K, Woo J, et al. Cholecystitis after placement of covered self-expandable metallic stents in patients with distal malignant biliary obstructions[J].Clin Endosc,2021,54(4): 589-595. DOI:10.5946/ce.2020.136. pmid:33198440
[25]	Robles-Medranda C, Oleas R, Puga-Tejada M, et al. Prophylactic EUS-guided gallbladder drainage prevents acute cholecystitis in patients with malignant biliary obstruction and cystic duct orifice involvement: a randomized trial (with video)[J].Gastrointest Endosc,2023,97(3): 445-453. DOI:10.1016/j.gie.2022.10.037.
[26]	Hemerly MC, de Moura DTH, do Monte Junior ES, et al. Endoscopic ultrasound(EUS)-guided cholecystostomy versus percutaneous cholecystostomy (PTC) in the management of acute cholecystitis in patients unfit for surgery: a systematic review and meta-analysis[J].Surg Endosc,2023,37(4): 2421-2438. DOI:10.1007/s00464-022-09712-x.
[27]	Matsumi A, Kato H, Ogawa T, et al. Risk factors and treatment strategies for cholecystitis after metallic stent placement for malignant biliary obstruction: a multicenter retrospective study[J].Gastrointest Endosc,2024,100(1): 76-84. DOI:10.1016/j.gie.2024.02.019.
[28]	Tejedor-Tejada J, Alvarez-Alvarez A, Olmos JM, et al. Secondary uncovered versus fully-covered metal stents for the management of occluded stent in unresectable distal malignant biliary obstruction[J].Gastroenterol Hepatol,2024,47(9): 502218. DOI:10.1016/j.gastrohep.2024.502218.
[29]	Cacaci M, De Maio F, Matteo MV, et al. Pilot study on cultural and metagenomic analysis of bile and biliary stentslead to unveiling the key players in stent occlusion[J].Sci Rep,2024,14(1): 3344. DOI:10.1038/s41598-024-51480-2.
[30]	Satoh T, Ishiwatari H, Kawaguchi S, et al. Comparing the 14-mm uncovered and 10-mm covered metal stents in patients with distal biliary obstruction caused by unresectable pancreatic cancer: a multicenter retrospective study[J].Surg Endosc,2022,36(1): 736-744. DOI:10.1007/s00464-021-08342-z.
[31]	Khizar H, Hu Y, Wu Y, et al. Efficacy and safety of radiofrequency ablation plus stent versus stent-alone treatments for malignant biliary strictures: a systematic review and meta-analysis[J].J Clin Gastroenterol,2023,57(4): 335-345. DOI:10.1097/mcg.0000000000001810.
[32]	Takenaka M, Kudo M. Endoscopic reintervention for recurrence of malignant biliary obstruction: developing the best strategy[J].Gut Liver,2022,16(4): 525-534. DOI:10.5009/gnl210228.
[33]	Do MY, Jang SI, Cho JH, et al. Safety and efficacy of a large-bore biliary metallic stent for malignant biliary obstruction[J].J Clin Med,2022,11(11): 3092. DOI:10.3390/jcm11113092.
[34]	Kitagawa K, Mitoro A, Ozutsumi T, et al. Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study[J].Clin Endosc,2022,55(3): 434-442. DOI:10.5946/ce.2021.161.
[35]	Xia MX, Zhou YF, Zhang M, et al. Influence of fully covered metal stenting on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: a large multicenter study[J].J Gastroenterol Hepatol,2020,35(12): 2256-2263. DOI:10.1111/jgh.15122.
[36]	Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis[J].Lancet Gastroenterol Hepatol,2021,6(9): 733-742. DOI:10.1016/s2468-1253(21)00170-9.
[37]	Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J].Endoscopy,2020,52(2): 127-149. DOI:10.1055/a-1075-4080.
[38]	Dell’Anna G, Ogura T, Vanella G, et al. Endoscopic ultrasound guided biliary interventions[J].Best Pract Res Clin Gastroenterol,2022, 60-61: 101810. DOI:10.1016/j.bpg.2022.101810.
[39]	Chen YI, Sahai A, Donatelli G, et al. Endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs endoscopic retrograde cholangiopancreatography in malignant distal biliary obstruction: a multicenter randomized controlled study (ELEMENT trial)[J].Gastroenterology,2023,165(5): 1249-1261.e5. DOI:10.1053/j.gastro.2023.07.024.
[40]	Giri S, Mohan BP, Jearth V, et al. Adverse events with EUS-guided biliary drainage: a systematic review and meta-analysis[J].Gastrointest Endosc,2023,98(4): 515-523.e18. DOI:10.1016/j.gie.2023.06.055.
[41]	Kamal F, Khan MA, Lee-Smith W, et al. Efficacy and safety of EUS-guided gallbladder drainage for rescue treatment of malignant biliary obstruction: a systematic review and meta-analysis[J].Endosc Ultrasound,2023,12(1): 8-15. DOI:10.4103/eus-d-21-00206.
[42]	Giri S, Seth V, Afzalpurkar S, et al. Endoscopic ultrasound-guided versus percutaneous transhepatic biliary drainage after failed ERCP: a systematic review and meta-analysis[J].Surg Laparosc Endosc Percutan Tech,2023,33(4): 411-419. DOI:10.1097/sle.0000000000001192.
[43]	Doyle JB, Sethi A. Endoscopic ultrasound-guided biliary drainage[J].J Clin Med,2023,12(7): 2736. DOI:10.3390/jcm12072736.
[44]	Inoue T, Yoneda M. Endoscopic intraductal radiofrequency ablation for extrahepatic cholangiocarcinoma: an update (2023)[J].World J Gastrointest Endosc,2023,15(6): 440-446. DOI:10.4253/wjge.v15.i6.440. pmid:37397976
[45]	Song S, Jin H, Cheng Q, et al. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials[J].Surg Endosc,2022,36(8): 5559-5570. DOI:10.1007/s00464-022-09181-2. pmid:35296949
[46]	Hayat U, Ashfaq MZ, Haseeb M, et al. Adjuvant radiofrequency ablation along with stenting versus stenting alone for biliary tree drainage in patients with malignant biliary strictures: a systemic review and meta-analysis[J].J Clin Gastroenterol,2024,58(3): 297-306. DOI:10.1097/mcg.0000000000001851.
[47]	Di Girolamo E, Belli A, Ottaiano A, et al. Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review[J].Front Oncol,2023,13: 1077794. DOI:10.3389/fonc.2023.1077794.